Angiogenic cytokines in induced sputum of patients with sarcoidosis

Respirology

Volumn 14, Issue 1, 2009, Pages 117-123

  Fireman, Elizabeth ^a,b   Gilburd, Daniel ^b   Marmor, Silvia ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiogenesis; IL 8; Induced sputum; Sarcoidosis; VEGF

Indexed keywords

INTERLEUKIN 8; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CD4 CD8 RATIO; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION TEST; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; SPUTUM ANALYSIS; T LYMPHOCYTE;

ADULT; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SARCOIDOSIS, PULMONARY; SPUTUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149141746     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01385.x     Document Type: Article

References (39)

1. Senger DR, Connolly DT, Van De Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990 50 : 1774 8.
2. Yeo T-K, Senger DR, Dvorak HF, Freter L, Yeo KT. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem. Biophys. Res. Commun. 1991 179 : 1568 75.
3. Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin. Cancer Biol. 1999 9 : 211 20.
4. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 1993 264 : C995 1002.
5. Koch AE, Harlow LA, Haines GK, Koch AH, Harlow LA et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 1994 152 : 4149 56.
6. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell Physiol. 1992 153 : 557 62.
7. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 2000 106 : 1311 19.
8. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003 167 : 1250 6.
9. Tzouvelekis A, Anevlavis S, Bouros D. Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? Respir. Res. 2006 7 : 82.
10. Antoniou KM, Tzouvelekis A, Alexandrakis MG, Sfiridaki K, Tsiligianni I et al. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006 130 : 982 8.
11. Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am. J. Respir. Crit. Care Med. 2004 169 : 1179 80.
12. Keane MP. Angiogenesis and pulmonary fibrosis: feast or famine? Am. J. Respir. Crit. Care Med. 2004 170 : 242 51.
13. Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS et al. Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 2004 59 : 581 5.
14. Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2004 169 : 1203 8.
15. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am. J. Respir. Crit. Care Med. 2004 170 : 242 51.
16. Mikami R, Sekiguchi M, Ryuzin Y, Kobayashi F, Hiraga Y et al. Changes in the peripheral vasculature of various organs in patients with sarcoidosis: possible role of microangiopathy. Heart Vessels 1986 2 : 129 39.
17. Meyer KC, Kaminski MJ, Calhoun WJ, Auerbach R. Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. I. Enhanced capacity of bronchoalveolar lavage cells from patients with pulmonary sarcoidosis to induce angiogenesis in vivo. Am. Rev. Respir. Dis. 1989 140 : 1446 9.
18. Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y. Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung 2003 181 : 259 65.
19. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S et al. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002 166 : 382 5.
20. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003 123 : 1520 6.
21. Matsuda M, Sakurai K, Fushimi T, Yamamoto K, Rokuhara S et al. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities. Clin. Rheumatol. 2004 23 : 246 8.
22. Miller MR, Crapo R, Hankinson J, Harkinson J, Brusasco V et al. Standardization of lung function testing: general considerations for lung function testing. Eur. Respir. J. 2006 26 : 158 61.
23. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992 47 : 25 9.
24. Popov T, Gottschalk R, Kolendowicz R, Dolovich J, Powers P et al. The evaluation of a cell dispersion method of sputum examination. Clin. Exp. Allergy. 1994 24 : 778 83.
25. Fireman E, Topilsky I, Greif J, Schwarz Y, Man A et al. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir. Med. 1999 93 : 827 34.
26. Fireman E, Boikaner T, Priel IE. Combined CD4/CD8 ratio in induced sputum and pulmonary function testing for non-invasive identification of sarcoidosis. Transl. Res. 2006 148 : 87 95.
27. Moodley YP, Dorasamy T, Venketasamy S, Naicker V, Lalloo UG. Correlation of CD4/CD8 ratio and TNF α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 2000 55 : 696 9.
28. McGarvey LP, Dunbar K, Martin SL, Brown V, Macmahon J et al. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers. J. Cyst. Fibros. 2002 1 : 269 75.
29. Mamessier E, Milhe F, Badier M, Thomas P, Magnan A et al. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. J. Heart Lung Transplant. 2006 25 : 523 32.
30. Maitre B, Boussat S, Jean D, Gouge M, Brochard L et al. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur. Respir. J. 2001 18 : 100 6.
31. Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B et al. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur. Respir. J. 2005 25 : 139 46.
32. Fireman E, Kraiem Z, Sade O, Greif J, Fireman Z. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin. Exp. Immunol. 2002 130 : 331 7.
33. Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J. Lab. Clin. Med. 2000 135 : 332 8.
34. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997 18 : 4 25.
35. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated t cells and induces Th1 polarization. J. Immunol. 2004 172 : 4618 23.
36. van der Vaart H, Postma DS, Timens W, Kauffman HF, Hylkema MN et al. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest 2006 130 : 1157 64.
37. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y et al. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. Am. J. Respir. Cell Mol. Biol. 2006 34 : 760 5.
38. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest 1980 78 : 640 7.
39. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir. Res. 2006 7 : 128.